0 Commentaires
0 Parts
306 Vue
0 Aperçu
Rechercher
Découvrez de nouvelles personnes, créer de nouvelles connexions et faire de nouveaux amis
- Connectez-vous pour aimer, partager et commenter!
- Biomaterials Market to Exhibit 12.2% CAGR till 2027; Rising Prevalence of Cardiovascular Diseases to Spur Growth: Fortune Business Insights™Global “Biomaterials Market Size” 2020 :- report presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers, Production, Revenue, Supply, Consumption, Export, Import, Industrial Chain, Sourcing Strategy and Downstream Buyers and Market Growth Factors Analysis in the market. To strategically profile the key players and...0 Commentaires 0 Parts 2232 Vue 0 Aperçu
- Cardiovascular Disease Monitoring and Diagnostic Devices Market Dynamics: Global Insights from 2024 to 2031The “Cardiovascular Disease Monitoring and Diagnostic Devices Market” most recent information on business innovations, applications, distribution methods, services, and geographic regions is condensed into one report. A thorough examination of major companies in the market has been carried out, providing insightful information on their business plans, mergers and acquisitions, and...0 Commentaires 0 Parts 321 Vue 0 Aperçu
- Cardiovascular Disease Monitoring and Diagnostic Devices Market Status and Outlook 2023-2031Cardiovascular Disease Monitoring and Diagnostic Devices Market report, it offers valuable insights into the industry landscape. The report sheds light on various aspects such as current market trends, growth potential, opportunities, and CAGR status. Furthermore, the report highlights the key factors that are driving the growth of the market. Additionally, the report provides a primary...0 Commentaires 0 Parts 462 Vue 0 Aperçu
- Gene Therapy in Cardiovascular Disorder Market Size, Share, Analysis and Forecast to 2030Gene therapy in cardiovascular disorder market is estimated to be worth US$ 178 million in 2023 and is projected to reach US$ 1,351.3 million by 2030, growing at a CAGR of 21.1% during the forecast period 2024-2030. This significant growth is driven by factors such as rising prevalence of cardiovascular diseases, increasing investments in gene therapy research and development, and growing...0 Commentaires 0 Parts 449 Vue 0 Aperçu
- GLP-1 Drug Market Size, Share, Growth Drivers, Trends, Opportunities & Forecast to 2030GLP-1 drug market is experiencing explosive growth, with a current value of US$20.43 billion and a projected CAGR of 25.7% to reach US$99.94 billion by 2029. This surge is driven by several factors, including the increasing prevalence of diabetes and obesity, the effectiveness of GLP-1 drugs in controlling these conditions, and their potential application in treating other diseases like...0 Commentaires 0 Parts 644 Vue 0 Aperçu
- Procedure Trays is Expected to Showcase a CAGR Of 9% due to the surge in cardiovascular diseases| Univdatos Market InsightsAccording to a new report published by UnivDatos Markets Insights, the procedure trays market was valued at USD 12 billion in 2021 & is expected to grow at a CAGR of 9% from 2022-2028. The analysis has been segmented into Product (Operating Room, Angiography, Ophthalmic, and Others); End User (Hospitals, Clinics, Ambulatory Surgical Centers, and Others); Region/Country. Click here to view...0 Commentaires 0 Parts 980 Vue 0 Aperçu
- The Impact of LDL-Cholesterol Lowering on Reducing Atherosclerotic Cardiovascular Disease RiskAtherosclerosis, characterized by the buildup of cholesterol-laden plaques within the arteries, is the root cause of the majority of cardiovascular events, including heart attacks, strokes, and peripheral artery disease. Decades of scientific research have firmly established a causal relationship between elevated low-density lipoprotein cholesterol (LDL-C) and the development and progression of...0 Commentaires 0 Parts 439 Vue 0 Aperçu
- Tissue Plasminogen Activator Market Poised to Grow at a Robust Pace Due to Rising Prevalence of Cardiovascular DiseasesThe global tissue plasminogen activator market is estimated to be valued at US$ 614.9 Mn in 2024 and is expected to exhibit a CAGR of 5.8% over the forecast period of 2024 to 2030. Tissue plasminogen activator (tPA) is a protein involved in the breakdown of blood clots. It helps restore blood flow by dissolving clots and is primarily used for the treatment of ischemic stroke and myocardial...0 Commentaires 0 Parts 93 Vue 0 Aperçu